Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol
Abstract Background Central nervous system tumors remain the leading cause of cancer-related mortality amongst children with solid tumors, with medulloblastoma (MB) representing the most common pediatric brain malignancy. Despite best current therapies, patients with recurrent MB experience have an...
Main Authors: | Ashley A. Adile, Michelle M. Kameda-Smith, David Bakhshinyan, Laura Banfield, Sabra K. Salim, Forough Farrokhyar, Adam J. Fleming |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Systematic Reviews |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13643-020-01307-8 |
Similar Items
-
Dynamic profiling of medulloblastoma surfaceome
by: David Bakhshinyan, et al.
Published: (2023-07-01) -
Is adult medulloblastoma merely the counterpart of pediatric medulloblastoma?
by: Gabriel Chun-Hei Wong, et al.
Published: (2020-01-01) -
Prognostic Clinical and Biologic Features for Overall Survival after Relapse in Childhood Medulloblastoma
by: Sophie Huybrechts, et al.
Published: (2020-12-01) -
Bevacizumab, irinotecan, and temozolomide with re-irradiation in adult recurrent medulloblastoma: A first case report
by: Takahiro Yamauchi, et al.
Published: (2021-09-01) -
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study
by: Christine Gaab, et al.
Published: (2022-01-01)